Company profilePharmaceutical#345 of 1,318 in Pakistan✓ No DRAP alerts

POPULAR CHEMICAL WORKS (PVT) LTD.

Pharmaceutical company · 51 brands · 61 molecules

Ranked #135 of 213 companies in Other Beta-Lactam, Cephalosporins & Penems

51 registered products 31 pharmaceutical brands 61 distinct molecules 0 DRAP alerts

Company overview

51
registered products
31
pharmaceutical brands
61
distinct molecules
11
therapeutic classes
0
DRAP alerts

POPULAR CHEMICAL WORKS (PVT) LTD. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 51 product registrations across 61 distinct molecules. Its portfolio is concentrated in Other Beta-Lactam, Cephalosporins & Penems and Blood Glucose Lowering Drugs, Excluding Insulin. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by POPULAR

30 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

26
ceilings with an approval date
0
not revised in 2+ years
2025
oldest approval year
202526

Top molecules by brand count

Risperidone4 brands
Amoxycillin3 brands
Cefixime3 brands
Artemether3 brands
Metformin3 brands
Lorazepam3 brands
Thiamine2 brands
Riboflavin2 brands
Nicotinamide2 brands
Levofloxacin2 brands

Therapeutic classes

Other Beta-Lactam, Cephalosporins & Penems · 2Blood Glucose Lowering Drugs, Excluding Insulin · 2Tonic · 1Antihistamines For Systemic Use · 1Antidepressants · 1Antihaemorrhagic · 1Psycholeptics; Antipsychotics, Anxiolytics, Hypnotics And Sedatives · 1Opioids · 1Pain Management · 1Antiinflammatory And Antirheumatic Products · 1Beta-Lactam Antibacterials, Penicillins · 1

Conditions treated

Arthritis · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official41 products · Rs 44.88 – Rs 608.2
Servaid1 products · Rs 625.2 – Rs 625.2
Median across source: Rs 625.2

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

Wilshire Laboratories (Private) Limited holds 124 molecules not in this portfolio
AcyclovirAcyclovir SodiumAlfacalcidolAmlodipineAmoxycillin BaseAnastrozole
IRZA PHARMA (PVT) LTD. holds 108 molecules not in this portfolio
AcetazolamideAcyclovirAdrenalineAlbendazoleAlbuterolAmikacin
Pharmatec Pakistan (Pvt.) Limited holds 120 molecules not in this portfolio
AmlodipineAmmonium ChlorideApixabanAripiprazoleAscorbic AcidAtorvastatin

Get the full profile for POPULAR

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.